Genelux Corp. Bolsters Finance with Shares Sale and Strategy Plan

Genelux Corp. (GNLX) has shared an announcement.

Genelux Corporation recently announced the partial exercise of an over-allotment option by underwriters, resulting in the sale of an additional 625,000 shares and warrants, generating approximately $2.35 million in net proceeds. The warrants, exercisable at $5.25 per share, come with an anti-dilution clause limiting individual holdings to under 19.99% to prevent a change of control. This financial move follows the company’s presentation of a corporate strategy, which will be used in future discussions. The details of these transactions are outlined in regulatory filings with the SEC.

See more insights into GNLX stock on TipRanks’ Stock Analysis page.